SOD1 and amyotrophic lateral sclerosis: For example, multi-omics approaches in ALS have identified that oxidized SOD1, nitrated neurofilament proteins, and double-fold changes in F2-isoprostanes could indicate biomarkers of disease progression and response to antioxidant treatment of edaravone.